Interaction of human arylamine n-acetyltransferase 1 with different nanomaterials

Drug Metabolism and Disposition

Volumn 42, Issue 3, 2014, Pages 377-383

  Deng, Zhou J ^a,b   Butcher, Neville J ^a   Mortimer, Gysell M ^a   Jia, Zhongfan ^a   Monteiro, Michael J ^a   Martin, Darren J ^a   Minchin, Rodney F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE N-ACETYLTRANSFERASE; BINDING SITES; HOT TEMPERATURE; HUMANS; ISOENZYMES; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, MOLECULAR; NANOPARTICLES; PARTICLE SIZE; POLYMERS; PROTEIN DENATURATION; SILICON DIOXIDE; SURFACE PROPERTIES; TITANIUM; ZINC OXIDE;

EID: 84893833671     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.055988     Document Type: Article

References (28)

1. Butcher NJ, Arulpragasam A, and Minchin RF (2004) Proteasomal degradation of Nacetyltransferase 1 is prevented by acetylation of the active site cysteine: a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation. J Biol Chem 279: 22131-22137.
2. Butcher NJ, Ilett KF, and Minchin RF (2000) Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol Pharmacol 57:468-473.
3. Butcher NJ and Minchin RF (2012) Arylamine N-acetyltransferase 1: a novel drug target in cancer development. Pharmacol Rev 64:147-165.
4. Chen N, Xiang X, and Heiden PA (2013) Tuning thermoresponsive behavior of diblock copolymers and their gold core hybrids. Part 2. How properties change depending on block attachment to gold nanoparticles. J Colloid Interface Sci 396:39-46.
5. Cruz JC, Pfromm PH, Tomich JM, and Rezac ME (2010) Conformational changes and catalytic competency of hydrolases adsorbing on fumed silica nanoparticles. I. Tertiary structure. Colloids Surf B Biointerfaces 79:97-104.
6. De Angelis I, Barone F, Zijno A, Bizzarri L, Russo MT, Pozzi R, Franchini F, Giudetti G, Uboldi C, Ponti J, et al. (2013) Comparative study of ZnO and TiO(2) nanoparticles: physicochemical characterisation and toxicological effects on human colon carcinoma cells. Nanotoxicology 7: 1361-1372.
7. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, and Minchin RF (2009) Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20:455101.
8. Ehrenberg M and McGrath JL (2005) Binding between particles and proteins in extracts: implications for microrheology and toxicity. Acta Biomater 1:305-315.
9. Grant DM (2008) Structures of human arylamine N-acetyltransferases. Curr Drug Metab 9: 465-470.
10. Jachak A, Lai SK, Hida K, Suk JS, Markovic N, Biswal S, Breysse PN, and Hanes J (2012) Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus. Nanotoxicology 6:614-622.
11. Jones RF, Land SJ, and King CM (1996) Recombinant rat and hamster N-acetyltransferases-1 and-2: relative rates of N-acetylation of arylamines and N,O-acyltransfer with arylhydroxamic acids. Carcinogenesis 17:1729-1733.
12. Jordan BJ, Hong R, Gider B, Hill J, Emrick T, and Rotello VM (2006) Stabilization of alphachymotrypsin at air-water interface through surface binding to gold nanoparticle scaffolds. Soft Matter 2:558-560.
13. Monopoli MP, Aberg C, Salvati A, and Dawson KA (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779-786.
14. Musumeci AW, Mortimer GM, Butler MK, Xu ZP, Minchin RF, and Martin DJ (2010) Fluorescent layered double hydroxide nanoparticles for biological studies. Appl Clay Sci 48: 271-279.
15. Patel HA, Somani RS, Bajaj HC, and Jasra RV (2006) Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulations, drug delivery vehicle and waste water treatment. Bull Mater Sci 29:133-145.
16. Pavlidou S and Papaspyrides CD (2008) A review on polymer-layered silicate nanocomposites. Prog Polym Sci 33:1119-1198.
17. Rodrigues-Lima F, Deloménie C, Goodfellow GH, Grant DM, and Dupret JM (2001) Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. Biochem J 356: 327-334.
18. Ryan JA, Overton KW, Speight ME, Oldenburg CN, Loo L, Robarge W, Franzen S, and Feldheim DL (2007) Cellular uptake of gold nanoparticles passivated with BSA-SV40 large T antigen conjugates. Anal Chem 79:9150-9159.
19. Saada MC, Montero JL, Vullo D, Scozzafava A, Winum JY, and Supuran CT (2011) Carbonic anhydrase activators: gold nanoparticles coated with derivatized histamine, histidine, and carnosine show enhanced activatory effects on several mammalian isoforms. J Med Chem 54: 1170-1177.
20. Sanfins E, Dairou J, Hussain S, Busi F, Chaffotte AF, Rodrigues-Lima F, and Dupret JM (2011) Carbon black nanoparticles impair acetylation of aromatic amine carcinogens through inactivation of arylamine N-acetyltransferase enzymes. ACS Nano 5:4504-4511.
21. Sebakhy KO, Kessel S, and Monteiro MJ (2010) Nanoreactors to synthesize well-defined polymer nanoparticles: decoupling particle size from molecular weight. Macromolecules 43: 9598-9600.
22. Segel IH (1975) Enzyme Kinetics, Wiley-Interscience, New York.
23. Sim E, Walters K, and Boukouvala S (2008) Arylamine N-acetyltransferases: from structure to function. Drug Metab Rev 40:479-510.
24. Tran NT, Truong NP, Gu W, Jia Z, Cooper MA, and Monteiro MJ (2013) Timed-release polymer nanoparticles. Biomacromolecules 14:495-502.
25. Urbani CN and Monteiro MJ (2009) Nanoreactors for aqueous RAFT-mediated polymerizations. Macromolecules 42:3884-3886.
26. Walkey CD and Chan WC (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41:2780-2799.
27. Wu Z, Zhang B, and Yan B (2009) Regulation of enzyme activity through interactions with nanoparticles. Int J Mol Sci 10:4198-4209.
28. Zhao F, Zhao Y, Liu Y, Chang X, Chen C, and Zhao Y (2011) Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 7:1322-1337.